Robert H Pietrzak1, Sandro Galea, Steven M Southwick, Joel Gelernter. 1. Clinical Neurosciences Division, National Center for Posttraumatic Stress Disorder, Veterans Affairs Connecticut Healthcare System, West Haven, CT 06516, USA. robert.pietrzak@yale.edu
Abstract
BACKGROUND: Little is known about the specificity of the interaction of serotonin transporter 5-HTTLPR genotype x trauma exposure in relation to contemporary structural models of PTSD symptomatology, which suggest that 4- or 5-factor models provide a better representation of the phenotypic expression of this disorder. METHODS: One hundred forty-nine respondents of a representative sample of adults affected by Hurricane Ike were interviewed 2-5 months after this 2008 disaster. RESULTS: After adjustment for age, sex, and ancestral proportion scores, the interaction of 5-HTTPLR genotype x trauma exposure was significantly associated with both severity (β=.40, p<.001) and probable diagnosis (Wald=4.55, p=.033; odds ratio=3.81, 95% CI=1.11-13.03) of Ike-related PTSD. Respondents with the low-expression variant of the 5-HTTPLR polymorphism (S allele carriers) who were highly exposed to Hurricane Ike reported significantly greater severity of PTSD symptoms and were more likely to screen positive for PTSD than respondents homozygous for the L allele who were highly exposed to Hurricane Ike. Confirmatory factor analyses revealed that a 5-factor model of intercorrelated re-experiencing, avoidance, numbing, dysphoric arousal, and anxious arousal symptoms provided the best structural representation of PTSD symptomatology. The 5-HTTPLR genotype x exposure interaction was significant only for anxious arousal (β=.44, p<.001) and re-experiencing (β=.35, p<.001) symptoms, but not avoidance, numbing, or dysphoric arousal symptoms (all βs≤.20, all ps>.13). LIMITATIONS: The small sample size and employment of self-report measures may limit generalizability of these findings. CONCLUSIONS: Results of this pilot study suggest that the low-expression variant of the 5-HTTLPR polymorphism modifies risk for PTSD, but that this effect may be specific to anxious arousal and re-experiencing symptoms. Published by Elsevier B.V.
BACKGROUND: Little is known about the specificity of the interaction of serotonin transporter5-HTTLPR genotype x trauma exposure in relation to contemporary structural models of PTSD symptomatology, which suggest that 4- or 5-factor models provide a better representation of the phenotypic expression of this disorder. METHODS: One hundred forty-nine respondents of a representative sample of adults affected by Hurricane Ike were interviewed 2-5 months after this 2008 disaster. RESULTS: After adjustment for age, sex, and ancestral proportion scores, the interaction of 5-HTTPLR genotype x trauma exposure was significantly associated with both severity (β=.40, p<.001) and probable diagnosis (Wald=4.55, p=.033; odds ratio=3.81, 95% CI=1.11-13.03) of Ike-related PTSD. Respondents with the low-expression variant of the 5-HTTPLR polymorphism (S allele carriers) who were highly exposed to Hurricane Ike reported significantly greater severity of PTSD symptoms and were more likely to screen positive for PTSD than respondents homozygous for the L allele who were highly exposed to Hurricane Ike. Confirmatory factor analyses revealed that a 5-factor model of intercorrelated re-experiencing, avoidance, numbing, dysphoric arousal, and anxious arousal symptoms provided the best structural representation of PTSD symptomatology. The 5-HTTPLR genotype x exposure interaction was significant only for anxious arousal (β=.44, p<.001) and re-experiencing (β=.35, p<.001) symptoms, but not avoidance, numbing, or dysphoric arousal symptoms (all βs≤.20, all ps>.13). LIMITATIONS: The small sample size and employment of self-report measures may limit generalizability of these findings. CONCLUSIONS: Results of this pilot study suggest that the low-expression variant of the 5-HTTLPR polymorphism modifies risk for PTSD, but that this effect may be specific to anxious arousal and re-experiencing symptoms. Published by Elsevier B.V.
Authors: Fran H Norris; Matthew J Friedman; Patricia J Watson; Christopher M Byrne; Eolia Diaz; Krzysztof Kaniasty Journal: Psychiatry Date: 2002 Impact factor: 2.458
Authors: Robert H Pietrzak; Peter H Van Ness; Terri R Fried; Sandro Galea; Fran Norris Journal: Int Psychogeriatr Date: 2012-05-30 Impact factor: 3.878
Authors: Robert H Pietrzak; Jack Tsai; Ilan Harpaz-Rotem; Julia M Whealin; Steven M Southwick Journal: J Psychiatr Res Date: 2011-12-09 Impact factor: 4.791
Authors: Pingxing Xie; Henry R Kranzler; Lindsay Farrer; Joel Gelernter Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2012-06-12 Impact factor: 3.568
Authors: Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger Journal: Science Date: 2002-07-19 Impact factor: 47.728
Authors: Allison E Ashley-Koch; Melanie E Garrett; Jason Gibson; Yutao Liu; Michelle F Dennis; Nathan A Kimbrel; Jean C Beckham; Michael A Hauser Journal: J Affect Disord Date: 2015-06-12 Impact factor: 4.839
Authors: Jeffrey S Simons; Raluca M Simons; Carol O'Brien; Scott F Stoltenberg; Jessica A Keith; Jaime A Hudson Journal: Addict Behav Date: 2016-09-04 Impact factor: 3.913
Authors: Erin C Dunn; Nadia Solovieff; Sarah R Lowe; Patience J Gallagher; Jonathan Chaponis; Jonathan Rosand; Karestan C Koenen; Mary C Waters; Jean E Rhodes; Jordan W Smoller Journal: J Affect Disord Date: 2013-10-01 Impact factor: 4.839